Crossmark

Design, synthesis, and in-vitro evaluation of 2-(heteroarylthio)acetamido-1H-benzo[d]imidazole derivatives as PTP1B inhibitors for the treatment of type 2 diabetes

Crossref DOI link: https://doi.org/10.1007/s13205-026-04824-w

Published Online: 2026-05-20

Published Print: 2026-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kumar, Praveen

Babalola, Benjamin Ayodipupo

Qu, Zihan

Waiker, Digambar Kumar

Moorthy, N. S. Hari Narayana

Tiwari, Akhilesh

Chourasiya, Arati

Kiriwan, Duangnapa

Martins, Fábio G.

Sousa, Sérgio F.

Zhang, Zhong-Yin

Karthikeyan, Chandrabose https://orcid.org/0000-0002-9074-9554
Funding

Funding for this research was provided by:

Indian Council of Medical Research (Letter No. 3/1/3(15)/Endo-fellowship/22-NCD-III)
License Information

Text and Data Mining valid from 2026-05-20

Version of Record valid from 2026-05-20
More Information

Article History

Received: 30 September 2025

Accepted: 8 April 2026

First Online: 20 May 2026

Declarations

:

: The authors declare no conflicts of interest.

Document is current

Any future updates will be listed below